| | Secteur
| Var. 1janv
 /  | Capitalisation (M$)
 / | Note Investissement
/ | CT
| MT
| LT
|
 |
| 1 - | JOHNSON & JOHNSON | Pharmacie - diversifié | -4.73% | 173 296 | |  |  | |
| 2 - | PFIZER INC. | Pharmacie - diversifié | 2.26% | 165 787 | | |  | |
| 3 - | MERCK & CO., INC. | Pharmacie - diversifié | -0.27% | 114 363 | | | | |
| 4 - | ABBOTT LABORATORIES | Pharmacie - diversifié | 10.71% | 98 211 | | | | |
| 5 - | BRISTOL MYERS SQUIBB .. | Pharmacie - diversifié | -6.38% | 55 522 | | | | |
| 6 - | AMGEN, INC. | Biotechnologie | 7.62% | 53 740 | | | | |
| 7 - | ELI LILLY & CO. | Pharmacie - diversifié | -1.06% | 47 763 | | | | |
| 8 - | GILEAD SCIENCES, INC. | Biotechnologie | 23.36% | 38 336 | | | | |
| 9 - | BIOGEN IDEC INC. | Biotechnologie | 19.55% | 31 538 | | | | |
| 10 - | CELGENE CORPORATION | Biotechnologie | 3.42% | 30 795 | | | | |
| 11 - | ALLERGAN, INC. | Pharmacie - générique/spéciali... | 3.18% | 27 463 | | | | |
| 12 - | MCKESSON CORPORATION | Pharmacie - générique/spéciali... | 11.65% | 20 477 | | | | |
| 13 - | ALEXION PHARMACEUTICA.. | Pharmacie - diversifié | 29.26% | 17 403 | | | | |
| 14 - | VERTEX PHARMACEUTICAL.. | Biotechnologie | 92.98% | 13 527 | | | | |
| 15 - | REGENERON PHARMACEUTI.. | Biotechnologie | 138.44% | 12 338 | | | | |
| 16 - | PERRIGO COMPANY | Pharmacie - générique/spéciali... | 5.78% | 9 615 | | | | |
| 17 - | WATSON PHARMACEUTICAL.. | Pharmacie - diversifié | 20.58% | 9 270 | | | | |
| 18 - | AMERISOURCEBERGEN COR.. | Pharmacie - générique/spéciali... | -0.78% | 9 223 | | | | |
| 19 - | MYLAN INC. | Pharmacie - diversifié | -0.84% | 9 122 | | | | |
| 20 - | FOREST LABORATORIES, .. | Pharmacie - générique/spéciali... | 10.31% | 8 850 | | | | |
| 21 - | LIFE TECHNOLOGIES COR.. | Biotechnologie | 7.50% | 7 502 | | | | |
| 22 - | HOSPIRA, INC. | Pharmacie - générique/spéciali... | 6.62% | 5 281 | | | | |
| 23 - | WARNER CHILCOTT PLC | Pharmacie - diversifié | 33.51% | 5 038 | | | | |
| 24 - | IDEXX LABORATORIES, I.. | Pharmacie - générique/spéciali... | 11.90% | 4 746 | | | | |
| 25 - | BIOMARIN PHARMACEUTIC.. | Pharmacie - diversifié | 12.39% | 4 456 | | | | |
| 26 - | AMYLIN PHARMACEUTICAL.. | Pharmacie - diversifié | 145.69% | 4 202 | | | | |
| 27 - | ENDO PHARMACEUTICALS .. | Pharmacie - diversifié | -2.78% | 3 900 | | | | |
| 28 - | QIAGEN NV | Biotechnologie | 18.90% | 3 867 | | | | |
| 29 - | MEDIVATION, INC. | Biotechnologie | 89.50% | 3 223 | | | | |
| 30 - | ONYX PHARMACEUTICALS,.. | Biotechnologie | 5.60% | 2 987 | | | | |
| 31 - | SALIX PHARMACEUTICALS.. | Pharmacie - générique/spéciali... | 5.54% | 2 932 | | | | |
| 32 - | INCYTE CORPORATION | Biotechnologie | 49.30% | 2 903 | | | | |
| 33 - | ARIAD PHARMACEUTICALS.. | Pharmacie - diversifié | 36.90% | 2 793 | | | | |
| 34 - | HUMAN GENOME SCIENCES | Biotechnologie | 84.17% | 2 711 | | | | |
| 35 - | QUESTCOR PHARMACEUTIC.. | Pharmacie - générique/spéciali... | -1.18% | 2 590 | | | | |
| 36 - | COVANCE INC. | Biotechnologie | 0.83% | 2 556 | | | | |
| 37 - | TECHNE CORPORATION | Biotechnologie | 1.22% | 2 551 | | | | |
| 38 - | JAZZ PHARMACEUTICALS .. | Biotechnologie | 18.72% | 2 548 | | | | |
| 39 - | CUBIST PHARMACEUTICAL.. | Pharmacie - diversifié | 0.73% | 2 528 | | | | |
| 40 - | VIVUS, INC. | Pharmacie - générique/spéciali... | 154.05% | 2 470 | | | | |
| 41 - | SEATTLE GENETICS, INC.. | Biotechnologie | 23.54% | 2 417 | | | | |
| 42 - | UNITED THERAPEUTICS C.. | Biotechnologie | -9.69% | 2 291 | | | | |
| 43 - | PHARMACYCLICS, INC. | Biotechnologie | 121.32% | 2 279 | | | | |
| 44 - | MEDICIS PHARMACEUTICA.. | Pharmacie - générique/spéciali... | 9.77% | 2 171 | | | | |
| 45 - | MYRIAD GENETICS, INC. | Pharmacie - générique/spéciali... | 22.11% | 2 170 | | | | |
| 46 - | ALKERMES PLC | Biotechnologie | -7.03% | 2 077 | | | | |
| 47 - | THERAVANCE INC | Pharmacie - diversifié | -0.36% | 1 889 | | | | |
| 48 - | CHARLES RIVER LABORAT.. | Biotechnologie | 22.03% | 1 634 | | | | |
| 49 - | PAREXEL INTERNATIONAL.. | Biotechnologie | 28.50% | 1 571 | | | | |
| 50 - | AMARIN CORPORATION PL.. | Pharmacie - diversifié | 54.21% | 1 534 | | | | |
